about
Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer's disease.β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling.Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes.Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Amyloid β-peptide and Alzheimer's disease.
@en
Amyloid β-peptide and Alzheimer's disease.
@nl
type
label
Amyloid β-peptide and Alzheimer's disease.
@en
Amyloid β-peptide and Alzheimer's disease.
@nl
prefLabel
Amyloid β-peptide and Alzheimer's disease.
@en
Amyloid β-peptide and Alzheimer's disease.
@nl
P2860
P356
P1476
Amyloid β-peptide and Alzheimer's disease
@en
P2093
Jennifer Mayes
P2860
P304
P356
10.1042/BSE0560099
P50
P577
2014-01-01T00:00:00Z